- Home
- BNTX vs FWONK Comparison
BNTX vs FWONK Comparison
Compare BNTX & FWONK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- FWONK
- Stock Information
- Founded
- BNTX 2008
- FWONK 1950
- Country
- BNTX Germany
- FWONK United States
- Employees
- BNTX N/A
- FWONK N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- FWONK Broadcasting
- Sector
- BNTX Health Care
- FWONK Industrials
- Exchange
- BNTX Nasdaq
- FWONK Nasdaq
- Market Cap
- BNTX 28.3B
- FWONK 23.6B
- IPO Year
- BNTX 2019
- FWONK N/A
- Fundamental
- Price
- BNTX $120.01
- FWONK $96.84
- Analyst Decision
- BNTX Strong Buy
- FWONK Buy
- Analyst Count
- BNTX 16
- FWONK 4
- Target Price
- BNTX $145.28
- FWONK $102.33
- AVG Volume (30 Days)
- BNTX 735.7K
- FWONK 1.1M
- Earning Date
- BNTX 03-19-2025
- FWONK 02-27-2025
- Dividend Yield
- BNTX N/A
- FWONK N/A
- EPS Growth
- BNTX N/A
- FWONK N/A
- EPS
- BNTX N/A
- FWONK 1.15
- Revenue
- BNTX $3,390,698,192.00
- FWONK $3,716,000,000.00
- Revenue This Year
- BNTX N/A
- FWONK $20.73
- Revenue Next Year
- BNTX N/A
- FWONK $10.28
- P/E Ratio
- BNTX N/A
- FWONK $83.92
- Revenue Growth
- BNTX N/A
- FWONK 35.32
- 52 Week Low
- BNTX $76.53
- FWONK $64.37
- 52 Week High
- BNTX $131.49
- FWONK $102.33
- Technical
- Relative Strength Index (RSI)
- BNTX 51.85
- FWONK 51.44
- Support Level
- BNTX $115.66
- FWONK $96.62
- Resistance Level
- BNTX $124.49
- FWONK $102.33
- Average True Range (ATR)
- BNTX 4.94
- FWONK 2.80
- MACD
- BNTX -0.01
- FWONK -0.30
- Stochastic Oscillator
- BNTX 65.37
- FWONK 36.90
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About FWONK Liberty Media Corporation Series C Liberty Formula One
Formula One Group controls the exclusive commercial and promotional rights to the FIA Formula One World Championship series, and the monetization of those rights is the primary business of the group. The firm is responsible for development and promotion of the Formula One race series in concert with its three partners: the FIA (the regulatory body), the teams that participate in the series, and the series' commercial partners, which include the race promoters, broadcasters, sponsors, and advertisers. The F1 schedule in 2023 will encompass 23 races held on five continents. Formula One Group is a subsidiary of Liberty Media, which purchased the firm in January 2017. Formula One stock is a tracking stock for the assets under Formula One Group with Liberty Media.